Metsera (NASDAQ:MTSR) Shares Gap Down – Should You Sell?

Metsera, Inc. (NASDAQ:MTSR)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $29.16, but opened at $28.00. Metsera shares last traded at $28.04, with a volume of 95,958 shares changing hands.

Analysts Set New Price Targets

MTSR has been the topic of a number of recent research reports. Cantor Fitzgerald began coverage on shares of Metsera in a report on Tuesday, February 25th. They issued an “overweight” rating on the stock. Bank of America began coverage on Metsera in a research report on Tuesday, February 25th. They set a “buy” rating and a $38.00 price objective for the company. Guggenheim began coverage on Metsera in a research report on Tuesday, February 25th. They issued a “buy” rating and a $56.00 target price on the stock. Finally, Evercore ISI initiated coverage on shares of Metsera in a report on Tuesday, February 25th. They set an “outperform” rating for the company.

Metsera Stock Performance

Metsera (NASDAQ:MTSR) last issued its quarterly earnings results on Wednesday, March 26th. The company reported ($3.52) EPS for the quarter.

Metsera Company Profile

Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.